By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Apceth GmbH  

Max-Lebsche-Platz 30

  D-81377  M√ľnchen  Germany
Phone: 49-0-89-7009608 - 0 Fax: 49-0-89-7009608 - 79



Company News
bluebird bio (BLUE) And apceth Biopharma Establish Commercial Drug Product Manufacturing Agreement 12/15/2016 8:00:29 AM
Cynata Enters License Option Agreement With Apceth GmbH 5/9/2016 7:21:52 AM
Apceth GmbH And University of Cologne To Join Forces On Combination Cellular Immunotherapies For Cancer 7/10/2015 9:05:57 AM
Apceth GmbH Expands Further Its GMP Manufacturing Business 6/22/2015 8:36:54 AM
Apceth GmbH Names Ulrike Verzetnitsch As Chief Technical Officer 4/23/2015 10:28:24 AM
Apceth GmbH Initiates Phase II Clinical Trial For Pioneering Engineered Cell Therapy To Treat Gastrointestinal Cancer 3/26/2015 7:18:55 AM
Apceth GmbH 's Ground-Breaking First-In-Man, First-In-Class Clinical Trial In Oncology With Genetically Modified Mesenchymal Stem Cells Is Now Enrolling 1/23/2014 10:36:54 AM
Apceth GmbH Names Dr Stefanos Theoharis Chief Business Officer 9/5/2013 9:47:16 AM
As the First Biopharmaceutical Company Worldwide, Apceth GmbH Receives Approval for a Clinical Trial With Genetically Modified Adult Mesenchymal Stem Cells for the Treatment of Cancer 6/13/2013 9:03:54 AM
Apceth GmbH Received the Second Round of Funding for Its Innovative Stem Cell-Based Cancer Therapeutic as Part of the m4 Initiative of the Munich Biotech Cluster 2/4/2013 2:00:09 PM